Medical Genetic Laboratory and Molecular Pathology, Medical School, Casablanca, Morocco.
J Mol Neurosci. 2013 Jun;50(2):270-4. doi: 10.1007/s12031-012-9944-9. Epub 2013 Jan 8.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease. It is a common cause of infant mortality. Its incidence is estimated at 1 in 10,000. Clinically, age of onset and the symptoms can distinguish four types of SMA. The objective of this study is to make available to clinicians a reliable and reproducible test for the molecular diagnosis of SMA. We evaluate the benefits and limitations of three tests used in our laboratory (RFLP-PCR, sequencing, and qPCR).
脊髓性肌萎缩症(SMA)是一种严重的神经肌肉疾病。它是婴儿死亡的常见原因。其发病率估计为每 10000 例中有 1 例。临床上,发病年龄和症状可以区分 SMA 的四种类型。本研究的目的是为临床医生提供一种可靠且可重复的 SMA 分子诊断测试。我们评估了我们实验室使用的三种测试(RFLP-PCR、测序和 qPCR)的优缺点。